trending Market Intelligence /marketintelligence/en/news-insights/trending/gyJcsg1MrxYWouAOx0sk5A2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

US FDA issues several observations at Baxter's Indian facilities

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


US FDA issues several observations at Baxter's Indian facilities

The U.S. Food and Drug Administration recorded a number of violations at Claris Lifesciences Ltd's facilities in Ahmedabad, India, which are now owned by Baxter International Inc.

The U.S. FDA began the inspection in late July, immediately before Baxter acquired Claris' generic injectables unit.

The regulator completed its inspection Aug. 4.

Baxter said it would respond to the observations and implement corrective and preventive actions to address the regulator's concerns.